| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2437415
Max Phase: Preclinical
Molecular Formula: C31H35FN6O2
Molecular Weight: 542.66
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Nc1cc(CN2CCC(C(=O)N3CCC(n4c(=O)n(Cc5ccccc5)c5cc(F)ccc54)CC3)CC2)ccn1
Standard InChI: InChI=1S/C31H35FN6O2/c32-25-6-7-27-28(19-25)37(21-22-4-2-1-3-5-22)31(40)38(27)26-11-16-36(17-12-26)30(39)24-9-14-35(15-10-24)20-23-8-13-34-29(33)18-23/h1-8,13,18-19,24,26H,9-12,14-17,20-21H2,(H2,33,34)
Standard InChI Key: YQKOTNLRNQDUTM-UHFFFAOYSA-N
Associated Targets(non-human)
Histamine H3 receptor 1015 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 542.66 | Molecular Weight (Monoisotopic): 542.2806 | AlogP: 4.04 | #Rotatable Bonds: 6 |
| Polar Surface Area: 89.39 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 8.13 | CX LogP: 3.12 | CX LogD: 2.31 |
| Aromatic Rings: 4 | Heavy Atoms: 40 | QED Weighted: 0.40 | Np Likeness Score: -1.24 |
References
| 1. Zeng Q, Rosenblum SB, Yang Z, Jiang Y, McCormick KD, Aslanian RG, Duguma L, Kozlowski JA, Shih NY, Hey JA, West RE, Korfmacher WA, Berlin M, Boyce CW.. (2013) Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists., 23 (21): [PMID:24050887] [10.1016/j.bmcl.2013.08.012] |
Source
Source(1):